Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. Revenue 2016–2025
Dianthus Therapeutics Inc. annual/quarterly revenue history and growth rate from 2016 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Dianthus Therapeutics Inc. revenue for the quarter ending September 30, 2025 was 396000, a 81.77% decrease year-over-year.
- Dianthus Therapeutics Inc. revenue for the twelve months ending September 30, 2025 was 3.9 M, a 18.82% decrease year-over-year.
- Dianthus Therapeutics Inc. annual revenue for 2025 was 2.0 M, a 67.35% decrease from 2024.
- Dianthus Therapeutics Inc. annual revenue for 2024 was 6.2 M, a 120.63% increase from 2023.
- Dianthus Therapeutics Inc. annual revenue for 2023 was 2.8 M.
- Dianthus Therapeutics Inc. annual revenue for 2019 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Dianthus Therapeutics Inc. Market Cap — FAQ
Dianthus Therapeutics Inc. (DNTH) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNTH's market cap history?
The chart and table above show Dianthus Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.